Fundraising FoxSkinTe
1 known investors
Find your way into SkinTe
Sign up to see every warm intro you have to SkinTe
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SkinTe team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PolarityBio is a late-stage biotechnology company developing regenerative multicellular biologics for chronic wounds such as diabetic foot ulcers. Its lead investigational product, SkinTE, is an autologous cutaneous multicellular therapy under FDA priority review, with a focus on the United States market.
Investors · 1
Frequently asked questions
- What does SkinTe do?
- PolarityBio is a late-stage biotechnology company developing regenerative multicellular biologics for chronic wounds such as diabetic foot ulcers. Its lead investigational product, SkinTE, is an autologous cutaneous multicellular therapy under FDA priority review, with a focus on the United States market.
- Who are SkinTe's investors?
- SkinTe's investors include JUMP Investors.